41 results
Page 2 of 3
8-K
EX-1.1
9jsuoun
26 Aug 20
Ovid Therapeutics Announces Pricing of $50 Million Offering of Common Stock
4:10pm
8-K
EX-1.1
9gppivlkt0bq7
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm
8-K
EX-1.2
hvykkk1gxjtug2elf
7 Oct 19
Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock
9:29pm
8-K
EX-99.1
nngj3d8r2hpc7 5lc9tm
2 Jul 19
Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101 for the Treatment of Angelman Syndrome
8:05am
8-K
EX-1.2
a72t2zvz112
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
8-K
EX-1.1
fay5mjt2t tm9m
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
S-3
EX-1.2
pfy5z tyd
1 Jun 18
Shelf registration
5:14pm
10-K
m9ak038
29 Mar 18
Annual report
12:00am